JULIE HUTTON: Open Payments
NPI 1255801080 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 40 payments from 5 companies in 2025. Trend: 2023 $463 · 2024 $355 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 29 | $259 |
| Novartis Pharmaceuticals Corporation | 5 | $150 |
| Astellas Pharma US Inc | 4 | $70 |
| TOLMAR, INC. | 1 | $17 |
| pharmaand GmbH | 1 | $17 |
Products named: ORGOVYX, PLUVICTO, Xtandi, RUBRACA, Padcev.
Industry payments across NE — which companies pay providers there.
